Submitted by Anonymous on November 8, 2017 - 4:39pm
From Bench to Clinic: Potent and Selective BTK Inhibitors for the Treatment of RA & Lupus
Wendy Young, Ph.D.
Vice President
Small Molecule Discovery Chemistry
Genentech, Inc.
San Francisco, CA
Host: Dr. Peter T. Meinke
Tea : Yes
Tea Time: Tea at 3:45 PM
Date:
Monday, June 18, 2018 - 4:00pm to 5:00pm